On the other hand, Brahmer et al., reported that nivolumab treatment is devoid of cytotoxic effects and its efficacy was evident in squamous cell carcinoma patients with or without PD-L1 expression [44]. The gene discussed is CD274; the disease is squamous cell carcinoma.